We are a global biomedical technology company that offers advanced in-vitro diagnostic solutions. We develop, patent, manufacture and market IVD products. Our primary research and development focus is on gastrointestinal and inflammatory diseases where we have multiple diagnostic and therapeutic products in clinical trials.
To be the leader in the development of diagnostic-guided-therapies that will revolutionize care for patients suffering from Irritable Bowel Syndrome (IBS) and other inflammatory diseases.
Improving quality of life by developing and delivering extremely well designed and high-performing diagnostic products.
We are an experienced and large-scale manufacturer of FDA cleared and CE marked products. All of our products are CE marked for European and rest of the world sales and manufactured under EN ISO 13485:2016 certification.
Two Manufacturing Facilities
Our main campus is in Irvine, California. Our complex houses the company's headquarters, including administrative offices, laboratories, FDA and CE registered manufacturing facilities. We also operate a production facility in Mexicali, Mexico which is both EN ISO 13485 and FDA certified.
Depth of Scientific Leadership
The depth of our scientific leadership is truly exceptional and we have a proud history of product innovation spanning more than three decades in several major clinical areas.
Biomerica is a contract manufacturer for multinational pharma companies and other leading diagnostic organizations.
Chairman & CEO
Robert W. Carlson
Chief Commercial Officer
Hans Boehringer, PhD
Senior Vice President, POC Research & Development
Bonnie Qiu, M.Sci.
Sr. Director of Quality Assurance & Regulatory Affairs
Director of Marketing &
Astrid Starke, PhD
Director of Marketing
Lucy Liu, PhD
Director of Manufacturing & Technical Operations
Director of Sales
(Europe & South America)
Biomerica Recent News
Biomerica Forms Scientific Advisory Board for Colorectal Cancer Screening
Chaired by Dr. Brooks Cash, Chief of Gastroenterology and Hepatology at the University of Texas Health Center at Houston Scientific
Biomerica Receives Notice of Allowance from Canadian Patent Office for Patent Covering Irritable Bowel Syndrome (IBS) Food Sensitivity Testing & Treatment
Studies show that 13-20% of Canadians suffer from IBS at any given time 1 . The lifetime risk for a Canadian to
Biomerica Launches New Website for Its Aware® Breast Exam Device
Simple at-home breast exam device provides results within minutes Studies show increase in Breast Exam Sensitivity IRVINE, Calif. , Oct.
Get in touch with us
If you would like a Biomerica representative to contact you, please use the links below to be directed to the proper department.